ZA200904281B - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders - Google Patents

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

Info

Publication number
ZA200904281B
ZA200904281B ZA200904281A ZA200904281A ZA200904281B ZA 200904281 B ZA200904281 B ZA 200904281B ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 B ZA200904281 B ZA 200904281B
Authority
ZA
South Africa
Prior art keywords
diabetes
treatment
receptor agonists
metabolic disorders
heterocyclic
Prior art date
Application number
ZA200904281A
Other languages
English (en)
Inventor
Xin Chen
Peng Cheng
L Edward Clemens
Jeffrey D Johnson
Jingyuan Ma
Alison Murphy
Imad Nashashibi
Christopher J Rabbat
Jiangao Song
Maria E Wilson
Yan Zhu
Zuchun Zhao
Original Assignee
Metabolex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261614&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200904281(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Metabolex Inc filed Critical Metabolex Inc
Publication of ZA200904281B publication Critical patent/ZA200904281B/xx

Links

ZA200904281A 2006-12-28 2007-12-27 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders ZA200904281B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87790306P 2006-12-28 2006-12-28

Publications (1)

Publication Number Publication Date
ZA200904281B true ZA200904281B (en) 2010-08-25

Family

ID=40261614

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904281A ZA200904281B (en) 2006-12-28 2007-12-27 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

Country Status (5)

Country Link
CN (1) CN101616586B (es)
AR (1) AR064702A1 (es)
CL (1) CL2007003841A1 (es)
TW (1) TWI414523B (es)
ZA (1) ZA200904281B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
US20090270404A1 (en) * 2008-03-31 2009-10-29 Metabolex, Inc. Oxymethylene aryl compounds and uses thereof
CN102666553B (zh) 2009-10-01 2015-05-06 赛马拜制药公司 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐
JP5960683B2 (ja) * 2010-04-28 2016-08-02 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 殺真菌剤としてのケトヘテロアリールピペリジンおよび−ピペラジン誘導体
BR112012032248A2 (pt) * 2010-06-23 2016-09-13 Metabolex Inc composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
CN103467398B (zh) * 2013-09-03 2015-01-21 浙江医药高等专科学校 ***酰胺类化合物、其制备方法和其抗糖尿病用途
WO2015101957A2 (en) * 2014-01-06 2015-07-09 Rhizen Pharmaceuticals Sa Novel glutaminase inhibitors
US10292983B2 (en) 2016-08-03 2019-05-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN111072652B (zh) * 2018-10-19 2023-05-23 暨南大学 用于治疗糖尿病和/或相关病症的化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1829718A (zh) * 2003-07-14 2006-09-06 艾尼纳制药公司 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症
JP4958560B2 (ja) * 2003-12-24 2012-06-20 プロシディオン・リミテッド Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体

Also Published As

Publication number Publication date
CN101616586B (zh) 2014-08-13
CN101616586A (zh) 2009-12-30
TWI414523B (zh) 2013-11-11
TW200833688A (en) 2008-08-16
AR064702A1 (es) 2009-04-22
CL2007003841A1 (es) 2008-03-14

Similar Documents

Publication Publication Date Title
BRPI0814294A2 (pt) Agonistas de receptor heterocíclico ligado a n para o tratamento do diabetes e de desordens metabólicas.
ZA200904281B (en) Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
WO2007109135A3 (en) Neuromedin u receptor agonists and uses thereof
ZA200806510B (en) Heterobicyclic sulfonamide derivatives for the treatment of diabetes
EP1976377A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
ZA201008807B (en) Gip-based mixed agonists for treatment of metabolic disorders and obesity
EP1983972A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
ZA200900734B (en) Combination treatment for metabolic disorders
ZA200808963B (en) Compounds for the treatment of metabolic disorders
EP1981526A4 (en) ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
IL205381A0 (en) Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
EP2217073A4 (en) METHOD FOR THE TREATMENT OF METABOLISM DISORDER AND DEPRESSION WITH DOPAMINE RECEPTOR AGONISTS
IL193800A0 (en) Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
IL194189A0 (en) Combination treatment of metabolic disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
EP2051732A4 (en) DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS AND METHODS THEREFOR
HK1098155A1 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
IL197695A0 (en) 3-amino-pyridine derivatives for the treatment of metabolic disorders
IL201119A0 (en) Methods and compositions of derivatives of probucol for the treatment of diabetes
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
IL195920A0 (en) 3-(1h-indol-3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety
IL192982A0 (en) Compounds for the treatment of metabolic disorders